Related Experiment Video
Updated: Aug 9, 2026

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
Published on: November 10, 2013
Myco-synthesis of selenium nanoparticles and their anticancer properties: a review
Morenikeji Abel Oke1,2,3,4, Elijah Adegoke Adebayo1,2,3, Malik Maaza1,2
1UNESCO-UNISA-ITLABS/NRF Africa Chair in Nanosciences & Nanotechnology, School of Interdisciplinary Research & Graduate Studies (SIRGS0, College of Graduate Studies (CGS), University of South Africa (UNISA), Muckleneuk Ridge, PO Box 392, Pretoria, South Africa.
Abstract:
The effective management and treatment of cancer have become complex and challenging because of its rapid, uncontrollable growth, ability to evade the immune system, and the development of resistance to treatments. Biogenically synthesized selenium nanoparticles (SeNPs) have gained attention owing to their anticancer properties. The synthesis and development of nanoparticles (NPs) using fungi offer a promising approach to creating new products in nanobiotechnology. Various mycological cultures and their derived substances are promising because they are easy to handle, environmentally friendly, and are considered safe, tolerant, and capable of impressive intracellular metal accumulation or uptake. Fungi are exceptional in their ability to secrete enzymes both intracellularly and extracellularly. Their ability to produce a diverse array of metabolites, including enzymes, polysaccharides, proteins, and other biomolecules, makes them valuable bioreactors for NP synthesis. Myco-synthesis of NPs has revealed effective mechanisms in producing different metal and metalloid NPs. Several studies have confirmed the practical applications of these NPs spanning copious fields, comprising agriculture, medicine, and industry, benefiting goods, services, and mankind. This work presented a comprehensive and critical review of the Myco-synthesis of SeNPs and their anticancer potentials. It explores the exceptional properties of fungi as programmed bio-factories by systematically providing a comparative appraisal linking multiple fungal species, their synthesis condition, and secreted biomolecules to SeNPs physiological features. It provides a mechanistic insight into Myco-synthesized SeNPs extracellular versus intracellular pathways and expounds how physiological properties influence the anticancer efficacy and biosafety. Finally, the work integrates thein vitroandin vivoevidence, offering a translational insight into the therapeutic potentials of Myco-synthesized SeNPs.
Insights
Fungi can be programmed as bio-factories to create selenium nanoparticles (SeNPs) with significant anticancer properties. This review explores myco-synthesis of SeNPs, their mechanisms, and therapeutic potential.
Area of Science:
- Nanobiotechnology
- Mycology
- Cancer Therapeutics
Background:
- Cancer treatment faces challenges due to uncontrolled growth, immune evasion, and drug resistance.
- Biogenically synthesized selenium nanoparticles (SeNPs) show promise for anticancer applications.
- Fungi offer a safe, eco-friendly, and efficient platform for nanoparticle synthesis (myco-synthesis).
Purpose of the Study:
- To critically review the myco-synthesis of SeNPs.
- To explore the anticancer potential of myco-synthesized SeNPs.
- To link fungal properties to SeNP characteristics and anticancer efficacy.
Main Methods:
- Comprehensive literature review on myco-synthesis of SeNPs.
- Comparative analysis of fungal species, synthesis conditions, and biomolecules.
- Investigation of extracellular vs. intracellular synthesis pathways.
Main Results:
- Fungi serve as effective bio-factories for SeNP production.
- Myco-synthesized SeNPs exhibit promising anticancer properties.
- Fungal synthesis conditions influence SeNP characteristics and efficacy.
Conclusions:
- Myco-synthesis provides a sustainable route to anticancer SeNPs.
- Understanding synthesis pathways enhances SeNP therapeutic potential and biosafety.
- Evidence supports the translational application of myco-synthesized SeNPs in cancer therapy.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

